NTRK2 and central nervous system cancer: The PI3K/AKT and the MAPK/ERK pathways play pivotal roles in promoting cell cycling, proliferation, and survival in cancers [50, 51], and TrkB.T1 is suggested to be associated with PI3K signaling in glioma [48].